Search Details

Word: biotechs (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...biotech firm in Palo Alto, Calif., held exclusive rights to sell that particular type of hormone sample, known as human recombinant relaxin...

Author: By Nicholas M. Ciarelli and Daniel J. T. Schuker, CRIMSON STAFF WRITERSS | Title: Tear Down This Wall? | 5/23/2007 | See Source »

...sought to commercialize their discoveries through startup companies, but since the cash-strapped startups would compensate them in stock, they would not be able to continue research on their discoveries under the companies’ sponsorship. Thrall and other observers say those restrictions make it harder for academics and biotech firms to collaborate on potentially lifesaving treatments...

Author: By Nicholas M. Ciarelli and Daniel J. T. Schuker, CRIMSON STAFF WRITERSS | Title: Tear Down This Wall? | 5/23/2007 | See Source »

When a Medical School researcher obtains a patent, he or she often sells licensing rights to a small biotech startup rather than a pharmaceutical giant. Large firms often are unwilling to take risks on new and untested technologies...

Author: By Nicholas M. Ciarelli and Daniel J. T. Schuker, CRIMSON STAFF WRITERSS | Title: Tear Down This Wall? | 5/23/2007 | See Source »

...kinds of asterisks have been proposed over time: President Bush's affinity for signing statements (more than 500 in his first term alone) fall into this category: when he doesn't want to veto a law, he just asserts that it doesn't apply to him. Biotech entrepreneur Paul Abrams proposes that if the law funding embryonic stem cell research survives a Bush veto, Congress should allow for another little box on tax returns letting people check off whether they agree for their tax dollars to be used for research. "This mechanism would provide active acknowledgement of people's deeply...

Author: /time Magazine | Title: Should Politicians Customize the Constitution? | 1/15/2007 | See Source »

...than vacant building after vacant building,” he said. According to Boston Redevelopment Authority project manager Gerald Autler, it is questionable whether or not Harvard will have success in filling the space. “The property was available for sale because previous attempts to work with biotech tenants had failed,” Autler said. “I don’t necessarily think Harvard will be any more successful at attracting those tenants than the previous owners.” Autler also speculated that Harvard’s price was lower than that of previous...

Author: By Ariadne C. Medler, CRIMSON STAFF WRITER | Title: Harvard Buys Vacant Tech Center for Allston | 1/8/2007 | See Source »

First | Previous | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | Next | Last